首页> 外文期刊>BMC Nephrology >The Kidney Awareness Registry and Education (KARE) study: protocol of a randomized controlled trial to enhance provider and patient engagement with chronic kidney disease
【24h】

The Kidney Awareness Registry and Education (KARE) study: protocol of a randomized controlled trial to enhance provider and patient engagement with chronic kidney disease

机译:肾脏意识注册和教育(KARE)研究:一项随机对照试验的协议,以加强提供者和患者对慢性肾脏病的参与

获取原文
           

摘要

Background Chronic kidney disease (CKD) is common and is associated with excess mortality and morbidity. Better management could slow progression of disease, prevent metabolic complications, and reduce cardiovascular outcomes. Low patient awareness of CKD and ineffective patient-provider communication can impede such efforts. We developed provider and patient-directed interventions that harness health information technology to enhance provider recognition of CKD and delivery of guideline concordant care and augment patient understanding and engagement in CKD care. Methods/design We report the design and protocol of the Kidney Awareness Registry and Education (KARE) Study, a 2x2 factorial randomized controlled trial that examines the impact of a multi-level intervention on health outcomes among low-income English, Spanish and Cantonese-speaking patients with CKD in a safety net system. The intervention includes: (1) implementation of a primary care electronic CKD registry that notifies practice teams of patients’ CKD status and employs a patient profile and quarterly feedback to encourage provision of guideline-concordant care at point-of-care and via outreach; and (2) a language-concordant, culturally-sensitive self-management support program that consists of automated telephone modules, provision of low-literacy written patient-educational materials and telephone health coaching. The primary outcomes of the trial are changes in systolic blood pressure (BP) and the proportion of patients with BP control (≤140/90?mmHg) after one year. Secondary outcomes include patient understanding of CKD, participation in healthy behaviors, and practice team delivery of guideline-concordant CKD care. Discussion Results from the KARE study will provide data on the feasibility, effectiveness, and acceptability of technology-based interventions that support primary care efforts at improving health outcomes among vulnerable patients with CKD. Trial registration ClinicalTrials.gov, number: NCT01530958
机译:背景慢性肾脏病(CKD)很常见,并与过度的死亡率和发病率有关。更好的管理可以减缓疾病的进展,预防代谢并发症并降低心血管疾病的预后。患者对CKD的了解不足以及患者与提供者之间的沟通不畅可能会阻碍此类工作。我们开发了利用提供者和以患者为导向的干预措施,这些措施利用健康信息技术来增强提供者对CKD的认可度和指导性一致护理的交付,并增强患者对CKD护理的理解和参与。方法/设计我们报告了肾脏意识注册表和教育(KARE)研究的设计和方案,该研究是一项2x2析因随机对照试验,研究了多级干预对低收入英语,西班牙语和广东话的健康结局的影响。在安全网系统中使用CKD的患者。干预措施包括:(1)实施初级保健电子CKD注册中心,以向实践团队通知患者的CKD状态,并采用患者概况和季度反馈来鼓励在现场和通过外展提供指南一致的护理; (2)语言协调,对文化敏感的自我管理支持计划,其中包括自动电话模块,提供低素养的书面病人教育材料和电话健康指导。该试验的主要结果是一年后收缩压(BP)的变化和血压控制的患者比例(≤140/ 90?mmHg)。次要结果包括患者对CKD的了解,参与健康行为以及实践小组提供与指南相符的CKD护理。 KARE研究的讨论结果将提供有关基于技术的干预措施的可行性,有效性和可接受性的数据,这些干预措施可为改善CKD脆弱患者的健康状况提供支持,以支持初级保健工作。试验注册ClinicalTrials.gov,编号:NCT01530958

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号